Financhill
Sell
40

REX Quote, Financials, Valuation and Earnings

Last price:
$40.13
Seasonality move :
9.32%
Day range:
$39.02 - $40.51
52-week range:
$39.02 - $60.79
Dividend yield:
0%
P/E ratio:
10.48x
P/S ratio:
1.06x
P/B ratio:
1.25x
Volume:
1.2M
Avg. volume:
185.1K
1-year change:
-14.15%
Market cap:
$703.6M
Revenue:
$833.4M
EPS (TTM):
$3.82
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $417.7M $372.7M $774.8M $855M $833.4M
Revenue Growth (YoY) -14.17% -10.78% 107.91% 10.35% -2.53%
 
Cost of Revenues $397.3M $353.1M $684.2M $806.4M $735.2M
Gross Profit $20.4M $19.5M $90.6M $48.6M $98.2M
Gross Profit Margin 4.88% 5.24% 11.7% 5.68% 11.79%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $19.5M $17.6M $21.5M $22.8M $29.4M
Other Inc / (Exp) $1.4M $500K $6.6M $8.7M $13.9M
Operating Expenses $19.5M $17.6M $21.5M $22.8M $29.4M
Operating Income $870K $1.9M $69.1M $25.8M $68.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $6.5M $4.2M $75.8M $47.5M $98.5M
Earnings of Discontinued Ops. $3.5M $1.1M $4.4M -- --
Income Tax Expense -$2M -$546K $19M $9.5M $22.6M
Net Income to Company $8.5M $4.8M $56.8M $37.9M $75.9M
 
Minority Interest in Earnings -$4.6M -$2.9M -$8.8M -$10.2M -$15M
Net Income to Common Excl Extra Items $7.4M $3M $52.4M $27.7M $60.9M
 
Basic EPS (Cont. Ops) $0.39 $0.16 $2.92 $1.57 $3.49
Diluted EPS (Cont. Ops) $0.39 $0.16 $2.92 $1.57 $3.47
Weighted Average Basic Share $19M $18.5M $17.9M $17.6M $17.5M
Weighted Average Diluted Share $19M $18.5M $17.9M $17.6M $17.6M
 
EBITDA $27.4M $25.4M $92.7M $49.1M $91.9M
EBIT $870K $1.9M $69.1M $25.8M $68.8M
 
Revenue (Reported) $417.7M $372.7M $774.8M $855M $833.4M
Operating Income (Reported) $870K $1.9M $69.1M $25.8M $68.8M
Operating Income (Adjusted) $870K $1.9M $69.1M $25.8M $68.8M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $124.2M $203.1M $220.3M $221.1M $174.9M
Revenue Growth (YoY) 43.32% 63.48% 8.48% 0.36% -20.9%
 
Cost of Revenues $105.3M $177.9M $211M $181.8M $135.2M
Gross Profit $18.9M $25.2M $9.3M $39.3M $39.7M
Gross Profit Margin 15.24% 12.39% 4.21% 17.77% 22.69%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.3M $6.3M $5.8M $7.6M $8.4M
Other Inc / (Exp) $1.2M $349K $661K $4.7M $3.6M
Operating Expenses $4.3M $6.3M $5.8M $7.6M $8.4M
Operating Income $14.7M $18.8M $3.5M $31.7M $31.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $16.3M $19.2M $6.1M $41.3M $39.5M
Earnings of Discontinued Ops. -- $2M -- -- --
Income Tax Expense $5M $4.3M $1.2M $9.6M $9.4M
Net Income to Company $10.3M $14.9M $4.9M $31.6M $30.1M
 
Minority Interest in Earnings -$2.3M -$1.6M -$1.7M -$5.6M -$5.6M
Net Income to Common Excl Extra Items $9M $15.3M $3.2M $26.1M $24.5M
 
Basic EPS (Cont. Ops) $0.48 $0.85 $0.18 $1.49 $1.39
Diluted EPS (Cont. Ops) $0.48 $0.85 $0.18 $1.49 $1.38
Weighted Average Basic Share $18.4M $17.9M $17.6M $17.5M $17.6M
Weighted Average Diluted Share $18.4M $17.9M $17.6M $17.5M $17.7M
 
EBITDA $19.1M $24.7M $9.2M $37.2M $35.9M
EBIT $14.7M $18.8M $3.5M $31.7M $31.3M
 
Revenue (Reported) $124.2M $203.1M $220.3M $221.1M $174.9M
Operating Income (Reported) $14.7M $18.8M $3.5M $31.7M $31.3M
Operating Income (Adjusted) $14.7M $18.8M $3.5M $31.7M $31.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $367.4M $688.8M $866.8M $845.9M $671.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $344.6M $621.7M $799.7M $764.8M $567.6M
Gross Profit $22.8M $67.1M $67.1M $81.1M $104.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $19.2M $26.7M $16.8M $27.1M $28.4M
Other Inc / (Exp) $1.2M $3.1M $10.1M $11.8M $11.7M
Operating Expenses $19.2M $26.7M $16.8M $27.1M $28.4M
Operating Income $3.6M $40.4M $50.3M $54M $76M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $7M $44M $70.8M $79.4M $107.4M
Earnings of Discontinued Ops. -- $4.5M -$238K -- --
Income Tax Expense $3.1M $8.2M $18.1M $17.6M $24.7M
Net Income to Company $2.9M $35.8M $52.7M $61.8M $82.7M
 
Minority Interest in Earnings -$3.4M -$6M -$11.5M -$13.3M -$15M
Net Income to Common Excl Extra Items $4.1M $35.4M $41M $48.5M $67.6M
 
Basic EPS (Cont. Ops) $0.22 $1.92 $2.30 $2.78 $3.85
Diluted EPS (Cont. Ops) $0.22 $1.92 $2.30 $2.78 $3.82
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $25.3M $63.9M $73.9M $76.8M $98.5M
EBIT $3.6M $40.4M $50.3M $54M $76M
 
Revenue (Reported) $367.4M $688.8M $866.8M $845.9M $671.9M
Operating Income (Reported) $3.6M $40.4M $50.3M $54M $76M
Operating Income (Adjusted) $3.6M $40.4M $50.3M $54M $76M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $246.8M $562.8M $654.8M $645.8M $484.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $238.5M $504M $619.5M $578M $410.4M
Gross Profit $8.3M $58.8M $35.3M $67.8M $73.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $13.3M $22.4M $17.7M $22M $21M
Other Inc / (Exp) $168K $2.8M $6.2M $9.3M $7.1M
Operating Expenses $13.3M $22.4M $17.7M $22M $21M
Operating Income -$5M $36.3M $17.6M $45.8M $52.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$3.5M $39.2M $34.1M $66M $75M
Earnings of Discontinued Ops. -- $4.5M -- -- --
Income Tax Expense -$4.3M $8.3M $7.4M $15.4M $17.6M
Net Income to Company -$133K $30.9M $26.8M $50.6M $57.4M
 
Minority Interest in Earnings -$1.2M -$4.4M -$7.2M -$10.3M -$10.3M
Net Income to Common Excl Extra Items -$347K $30.9M $19.5M $40.4M $47.1M
 
Basic EPS (Cont. Ops) -$0.02 $1.72 $1.10 $2.31 $2.68
Diluted EPS (Cont. Ops) -$0.02 $1.72 $1.10 $2.31 $2.66
Weighted Average Basic Share $56M $54M $53.2M $52.4M $52.7M
Weighted Average Diluted Share $56M $54M $53.2M $52.4M $53.1M
 
EBITDA $12.5M $54M $35.2M $62.9M $69.6M
EBIT -$5M $36.3M $17.6M $45.8M $52.9M
 
Revenue (Reported) $246.8M $562.8M $654.8M $645.8M $484.3M
Operating Income (Reported) -$5M $36.3M $17.6M $45.8M $52.9M
Operating Income (Adjusted) -$5M $36.3M $17.6M $45.8M $52.9M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $179.7M $144.5M $229.8M $69.6M $223.4M
Short Term Investments $26.1M $36.2M $25.9M $211.3M $155.3M
Accounts Receivable, Net $13M $19.7M $25.8M $25.2M $23.2M
Inventory $35.6M $37.4M $42.2M $48.7M $27M
Prepaid Expenses -- -- -- -- --
Other Current Assets $9.7M $12.8M $12.5M $13.1M $17.5M
Total Current Assets $271.1M $258.8M $345.2M $372.6M $452.1M
 
Property Plant And Equipment $179.5M $163.5M $148.8M $150.7M $168.6M
Long-Term Investments $32.5M $29.5M $30.6M $33M $34.9M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $342K $3.2M $939K $1.2M $1.3M
Total Assets $500.5M $479.3M $550.4M $579.6M $664.8M
 
Accounts Payable $18.9M $16.6M $32.3M $34.1M $42.1M
Accrued Expenses $5.1M $4.8M $10.3M $9.9M $15.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $4.9M $4.9M $4.6M $5.2M $4.5M
Other Current Liabilities $891K $2.7M $1.4M $1.6M $2.2M
Total Current Liabilities $31.6M $30.7M $50.5M $54.6M $66.3M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $46.9M $42.2M $62.8M $68.6M $77.2M
 
Common Stock $299K $299K $299K $299K $299K
Other Common Equity Adj -- -- -- -- --
Common Equity $401M $384.8M $430.8M $448M $513.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $52.6M $52.4M $56.8M $63M $73.7M
Total Equity $453.6M $437.2M $487.6M $511M $587.6M
 
Total Liabilities and Equity $500.5M $479.3M $550.4M $579.6M $664.8M
Cash and Short Terms $205.7M $180.7M $255.7M $280.9M $378.7M
Total Debt -- -- -- -- --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $173.1M $197.4M $136M $72.8M $298.2M
Short Term Investments $29.2M $21.6M $153.8M $259.2M $66.8M
Accounts Receivable, Net $12.5M $40M $22.7M $30.1M $22.3M
Inventory $21.6M $29.8M $42M $37.5M $29.1M
Prepaid Expenses -- -- -- -- --
Other Current Assets $9.8M $10.4M $11.6M $12.3M $14.4M
Total Current Assets $253M $307.2M $374M $418.1M $436.5M
 
Property Plant And Equipment $168.5M $153M $146M $159.1M $223.1M
Long-Term Investments $30.1M $30.7M $33.8M $36.8M $39M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.3M $33.4M $21.3M $1.7M $1.5M
Total Assets $475.2M $524.4M $575M $627.6M $715.7M
 
Accounts Payable $15.6M $27.1M $40.3M $28.8M $22.2M
Accrued Expenses $3.8M $7.8M $8.8M $10.6M $11.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $5.1M $5M $4.9M $5.1M $5.9M
Other Current Liabilities $893K $5.1M $1.7M $2.7M $3.4M
Total Current Liabilities $26.7M $46.5M $57.3M $48.7M $44M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $39.7M $59.7M $73.3M $62M $69.1M
 
Common Stock $299K $299K $299K $299K $299K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $53.5M $55.4M $62.3M $72.6M $82.1M
Total Equity $435.5M $464.7M $501.7M $565.5M $646.6M
 
Total Liabilities and Equity $475.2M $524.4M $575M $627.6M $715.7M
Cash and Short Terms $202.3M $219M $289.8M $332M $365.1M
Total Debt -- -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders $8.5M $4.8M $56.8M $37.9M $75.9M
Depreciation & Amoritzation $26.5M $23.5M $23.6M $23.3M $23M
Stock-Based Compensation $397K $264K $1.8M $1.9M $6.2M
Change in Accounts Receivable -$308K -$7M -$7.2M $4.4M -$789K
Change in Inventories -$17.1M -$2.3M -$4.8M -$6.5M $21.8M
Cash From Operations $10.3M $8.6M $91.7M $54.8M $128M
 
Capital Expenditures $3.8M $10.4M $5.1M $15.6M $37.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$14.4M -$20.8M $5.3M -$198.5M $28.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$19.6M -$6.6M -$13M --
Other Financing Activities -$4M -$2.9M -$4.8M -$4M -$4.3M
Cash From Financing -$4M -$22.4M -$11.1M -$17M -$4.3M
 
Beginning Cash (CF) $188.8M $180.8M $146.2M $232.1M $71.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$8M -$34.6M $85.9M -$160.7M $152.1M
Ending Cash (CF) $180.8M $146.2M $232.1M $71.3M $223.4M
 
Levered Free Cash Flow $6.6M -$1.8M $86.6M $39.2M $90.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $10.3M $14.9M $4.9M $31.6M $30.1M
Depreciation & Amoritzation $4.4M $5.8M $5.8M $5.6M $4.6M
Stock-Based Compensation $42K $533K $439K $1.3M $1.2M
Change in Accounts Receivable $1.7M -$9.7M $15.2M $3.1M $1.6M
Change in Inventories $8.7M $11.6M $7.9M $8.4M $35K
Cash From Operations $30.5M $33.3M $53.2M $58.8M $33.4M
 
Capital Expenditures $918K $1.6M $4.2M $14.2M $15.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing $2.3M $10.1M $33M -$88.2M $3.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$12.5M -$5.3M -$6.8M -- --
Other Financing Activities -$61K -$211K -$97K -- -$47K
Cash From Financing -$12.6M -$5.3M -$6.9M -- -$47K
 
Beginning Cash (CF) $153.7M $161.1M $58M $102.2M $261M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $20.3M $38.1M $79.3M -$29.3M $37.2M
Ending Cash (CF) $174M $199.1M $137.3M $72.8M $298.2M
 
Levered Free Cash Flow $29.6M $31.7M $49M $44.7M $18.2M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $2.9M $35.8M $52.7M $61.8M $82.7M
Depreciation & Amoritzation $21.8M $23.5M $23.6M $22.8M $22.5M
Stock-Based Compensation $304K $1.2M $1.9M $5.8M $4M
Change in Accounts Receivable $4.6M -$28M $16.6M -$5.3M $6.7M
Change in Inventories $9.4M -$8.6M -$12.3M $4.5M $8.4M
Cash From Operations $34.2M $37.6M $95.3M $66.3M $101.6M
 
Capital Expenditures $7.7M $8M $8.1M $30.8M $70.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$37.2M -$359K -$139.1M -$127.7M $129.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$18.1M -- -- -- --
Other Financing Activities -$1.8M -$4.2M -$5M -$3M -$5.5M
Cash From Financing -$19.9M -$12M -$18M -$3M -$5.5M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$22.9M $25.2M -$61.8M -$64.5M $225.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $26.4M $29.5M $87.2M $35.5M $30.9M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -$133K $30.9M $26.8M $50.6M $57.4M
Depreciation & Amoritzation $17.6M $17.6M $17.6M $17.1M $16.6M
Stock-Based Compensation $122K $1.1M $1.3M $5.1M $3M
Change in Accounts Receivable $343K -$20.6M $3.2M -$6.5M $1M
Change in Inventories $14M $7.7M $180K $11.2M -$2.1M
Cash From Operations $21.5M $50.4M $54M $65.5M $39.1M
 
Capital Expenditures $6.6M $4.2M $7.2M $22.4M $55.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$10M $10.4M -$134M -$63.3M $37.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$18.1M -$6.6M -$13M -- --
Other Financing Activities -$195K -$1.5M -$1.7M -$716K -$1.9M
Cash From Financing -$18.3M -$7.9M -$14.7M -$716K -$1.9M
 
Beginning Cash (CF) $499.6M $466.1M $361.6M $251.2M $715.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$6.8M $53M -$94.8M $1.5M $74.9M
Ending Cash (CF) $492.8M $519M $266.9M $252.7M $790.5M
 
Levered Free Cash Flow $14.9M $46.2M $46.8M $43.1M -$16.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.55% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock